Ernexa Therapeutics Inc. (ERNA) stock

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$1.93−0.08 (-3.98%)

Close on Nov 11, 2026Market cap $3.15MP/E –Yield –

Ernexa Therapeutics statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $3.15M; $282.97M
Enterprise Value: -$2.42M; $154.96M
PB Ratio: 0.72; 2.17
P/TBV Ratio: 0.72; 2.39

Share statisticsIndustry

Shares Outstanding: 2M; 58M
Shares Change (QoQ): 40.6%; 0.51%

Short sellingIndustry

Short Interest: 33,263; –
Short Interest Change: 67.3%; -0.76%
Days to Cover: 2.03; 5.16

Stock price statisticsIndustry

52-Week High: $41.99; –
52-Week Low: $1.74; –
20-Day Moving Average: $2.02; –
50-Day Moving Average: $2.86; –
200-Day Moving Average: $6.23; –
Average True Range (14): $0.22; –
Price Change (1 Week): -3.02%; -0.50%
Price Change (1 Month): -12.7%; -0.33%
Price Change (3 Months): -55.1%; -17.2%
Price Change (6 Months): -84.1%; -20.1%
Price Change (YTD): -93.6%; -20.1%
Price Change (1 Year): -95.4%; -19.3%
Price Change (3 Years): -99.6%; -23.4%
Price Change (5 Years): -100.0%; -76.4%
Price Change (10 Years): -100.0%; -62.4%
Average Volume (10 Days): 14,275; –
Average Volume (20 Days): 16,053; –
Average Volume (90 Days): 343,708; –
Relative Volume: 0.03; 0.73
Relative Strength Index (14): 37.3; 47.6
Volatility (1 Year): 152.2%; 80.2%
Beta (5 Years): 1.59; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -352.4%; -51.3%
Return on Assets (ROA): -210.3%; -40.3%
Return on Capital Employed (ROCE): -329.1%; -37.7%

Financial positionIndustry

Current Ratio: 2.57; 3.30
Quick Ratio: 2.13; 2.37

EfficiencyIndustry

Profits Per Employee: -$2.79M; -$680.86K
Employee Count: 5; 75
WACC: 12.8%; 10.1%

Income statement (TTM)Industry

Operating Income: -$14.78M; -$20.20M
Pretax Income: -$14.06M; -$13.50M
Net Income: -$13.96M; -$21.57M
EBITDA: -$14.56M; -$16.36M

Balance sheetIndustry

Cash & Short-Term Investments: $5.58M; $65.30M
Net Cash (Debt): $5.58M; $16.31M
Net Cash Per Share: $3.42; $0.70
Equity (Book Value): $4.35M; $53.12M
Book Value Per Share: $2.67; $1.49
Tangible Book Value: $4.35M; $26.11M
Working Capital: $4.11M; $77.59M

Cash flow (TTM)Industry

Operating Cash Flow: -$10.73M; -$12.07M
Capital Expenditures: -$20.00K; -$939.00K
Free Cash Flow: -$10.75M; -$18.37M
FCF Per Share: -$6.59; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -443.0%; -19.8%
FCF Yield: -341.3%; -8.81%

Taxes and interestIndustry

Income Tax: -$102.00K; $79.50K

Scores and fair valueIndustry

Altman Z-Score: -56.35; 0.28
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	ERNA	S&P 500	Difference	ERNA per year	S&P 500 per year
1 month	-19.6%	-2.4%	−17.2 pts
3 months	-56.0%	-1.2%	−54.9 pts
Year to date	-93.6%	+12.3%	−105.9 pts
1 year	-95.1%	+12.4%	−107.6 pts
3 years	-99.6%	+78.8%	−178.4 pts	-83.7%	+21.4%
5 years	-100.0%	+75.2%	−175.2 pts	-87.5%	+11.9%
10 years	-100.0%	+311.1%	−411.1 pts	-66.6%	+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ERNA shares were sold short on Oct 30, 2026, up 67.3% from the previous report. At recent volumes it would take 2.0 days to buy them back. Over the last 20 sessions, 33.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	33,263	+67.3%	16,424	2.0
Oct 15, 2026	19,877	+0.8%	105,857	1.0
Sep 30, 2026	19,725	+37.4%	23,717	1.0
Sep 15, 2026	14,361	-27.5%	69,218	1.0
Aug 31, 2026	19,798	-19.7%	36,104	1.0
Aug 14, 2026	24,656	+68.8%	47,948	1.0
Jul 31, 2026	14,605	-0.9%	111,110	1.0
Jul 15, 2026	14,740	-49.8%	2,478,882	1.0
Jun 30, 2026	29,381	-27.6%	69,259	1.0
Jun 15, 2026	40,604	-9.4%	45,433	1.0
May 29, 2026	44,811	-72.4%	99,259	1.0
May 15, 2026	162,618	+21.7%	8,817,187	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?